查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612554

生物晶片市场：按类型、製造技术、应用和最终用户划分 - 全球预测 2025-2030

Biochips Market by Type (Arrays, DNA Chips, Lab-On-A-Chip), Fabrication Technology (Microarrays, Microfluidics), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物晶片市值为202.9亿美元，预计2024年将达到241亿美元，复合年增长率为19.44%，到2030年将达到704亿美元。

生物晶片是生物技术领域的革命性组件，可作为小型实验室，可以同时进行数百或数千个生化反应。其范围超出了诊断、药物发现、基因组学、蛋白质组学和个人化医疗，以提高效率和精确度。生物晶片因其在筛检和快速分析方面的高性能和效用而受到越来越多的需求，满足了对个人化医疗解决方案和简化药物开发流程的需求。在世界对健康和永续实践日益增长的兴趣的推动下，它在医学、农业和环境监测等各个领域都有应用。主要最终用户包括製药公司、研究机构和医疗诊断公司。生物晶片市场的成长受到技术进步、研究经费增加以及需要先进诊断工具的慢性病盛行率上升的影响。随着生物资讯学和人工智慧技术的融合，个人化医疗和就地检验有着广阔的前景。公司可以透过投资多功能生物晶片的研发、提高灵敏度以及寻求与高科技公司合作以获得尖端解决方案来获得资金。

主要市场统计
基准年[2023] 202.9亿美元
预测年份 [2024] 241亿美元
预测年份 [2030] 704亿美元
复合年增长率（%） 19.44%

然而，市场并非没有挑战。高成本、严格的监管要求以及对与生物晶片开发相关的专业知识的需求是主要障碍。此外，资料隐私和生物晶片标准化问题也可能阻碍成长。为了克服这些担忧，相关人员应专注于具有成本效益的生产技术，并努力建立通用标准。创新在于扩大生物晶片在食品安全和法医学等非传统领域的应用，并提高生物相容性和可扩展性以实现更广泛的采用。竞争格局是动态的，主要参与企业之间不断进步并加强合作。这些不断变化的市场动态表明技术创新的巨大潜力，特别是在开发生物晶片技术以满足不断增长的全球健康需求方面，从而确保可持续的业务成长和市场扩张。

市场动态：揭示快速发展的生物晶片市场的关键市场洞察

供需的动态相互作用正在改变生物晶片市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 危及生命的疾病增加，老年人数量增加
    • 癌症治疗中个人化医疗的需求不断增长
    • 就地检验的需求增加
  • 市场限制因素
    • 与製造生物晶片产品相关的高成本
  • 市场机会
    • 基因组学和蛋白​​质组学领域的持续进步
    • 私营和公共部门增加对生物技术领域的投资
  • 市场问题
    • 与生物晶片製造和部署相关的严格法规

波特五力：驾驭生物晶片市场的策略工具

波特的五力框架是了解生物晶片市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物晶片市场的外部影响

外部宏观环境因素在塑造生物晶片市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解生物晶片市场的竞争格局

对生物晶片市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：生物晶片市场供应商绩效评估

FPNV定位矩阵是评估生物晶片市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製生物晶片市场的成功之路

生物晶片市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 危及生命的疾病发生率不断上升，老年人口数量不断增加
      • 癌症治疗中个人化医疗的需求不断增长
      • 就地检验的需求增加
    • 抑制因素
      • 与製造生物晶片产品相关的高成本
    • 机会
      • 基因组学和蛋白​​质组学领域的持续进步
      • 私营和公共部门增加对生物技术领域的投资
    • 任务
      • 与生物晶片製造和实施相关的严格规定
  • 市场区隔分析
    • 类型：消费者更喜欢使用实验室晶片进行照护现场诊断，因为它们可以提供快速、准确的结果
    • 製造技术：微流体在病原体检测的照护现场诊断的广泛使用
    • 应用：生物晶片在药物发现中的重要作用，用于化合物识别和标靶检验
    • 最终用户：生物晶片在生物技术和製药公司的新药发现和个人化医疗中越来越受欢迎。
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章生物晶片市场：依类型

  • 介绍
  • 大批
    • 帽阵列
    • 组织阵列
  • DNA晶片
  • 实验室晶片
  • 蛋白质晶片

第七章生物晶片市场：依製造技术分类

  • 介绍
  • 微阵列
  • 微流体

第八章生物晶片市场：依应用分类

  • 介绍
  • 临床诊断
  • 药物发现
  • 基因组学和蛋白​​质组学来源

第九章生物晶片市场：依最终用户分类

  • 介绍
  • 学术研究所
  • 生物技术和製药公司
  • 医院和诊断中心

第十章美洲生物晶片市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太生物晶片市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲生物晶片市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Archer 的第一代生物晶片 gFET 设计透过与晶圆代工厂合作伙伴共同製造检验
    • Opteev 申请新型多重生物晶片专利
    • Nutcracker Therapeutics 筹集了 1.67 亿美元的 C 系列资金筹措，以推进 mRNA 疗法和第一个基于生物晶片的製造平台的开发
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • ACROBiosystems Inc.
  • Agilent Technologies, Inc.
  • Archer Materials Limited
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • Cellix Ltd. by Randox Laboratories Ltd.
  • Diagnostic Biochips, Inc
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies, Inc.
  • Horiba, Ltd.
  • Illumina, Inc.
  • Innovative Biochips, LLC
  • LI-COR, Inc.
  • Luminex Corporation by DiaSorin SpA
  • Merck KGaA
  • Micronit BV
  • Nutcracker Therapeutics
  • Opteev
  • PerkinElmer Inc.
  • Phalanx BIoTech Group Inc. by WIN Semiconductors Corp.
  • QIAGEN NV
  • Sphere Fluidics Limited
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-430D42AA0CE3

The Biochips Market was valued at USD 20.29 billion in 2023, expected to reach USD 24.10 billion in 2024, and is projected to grow at a CAGR of 19.44%, to USD 70.40 billion by 2030.

Biochips represent a revolutionary component within biotechnology, serving as miniaturized laboratories capable of performing hundreds or thousands of simultaneous biochemical reactions. Their scope transcends diagnostics, drug discovery, genomics, proteomics, and personalized medicine, enhancing efficiency and precision. Biochips are increasingly necessary due to their utility in high-throughput screening and rapid analysis, which support the demand for personalized healthcare solutions and streamlined drug development processes. They find applications across various sectors including healthcare, agriculture, and environmental monitoring, driven by the rising global focus on health and sustainable practices. Key end-users include pharmaceutical companies, research institutions, and medical diagnostics companies. Market growth for biochips is influenced by technological advancements, increasing funding for research, and rising prevalence of chronic diseases demanding advanced diagnostic tools. There are promising opportunities in personalized medicine and point-of-care testing, driven by the integration of bioinformatics and AI technologies. Businesses can capitalize by investing in R&D for multi-functional biochips, enhancing sensitivity, and exploring partnerships with tech companies for cutting-edge solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 20.29 billion
Estimated Year [2024] USD 24.10 billion
Forecast Year [2030] USD 70.40 billion
CAGR (%) 19.44%

However, the market is not without its challenges. High costs associated with biochip development, stringent regulatory requirements, and the need for specialized knowledge pose significant barriers. Additionally, issues related to data privacy and biochip standardization can hinder growth. To overcome these concerns, stakeholders should focus on cost-effective production techniques and work towards establishing universal standards. Innovation lies in the expansion of biochip applications in non-traditional fields like food safety and forensics, and improving biocompatibility and scalability for broader adoption. The competitive landscape is dynamic, with continuous advancements and increasing collaborations among key players. These evolving market dynamics suggest a significant potential for innovation, particularly in developing biochip technologies that cater to growing global health demands, thereby ensuring sustainable business growth and market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biochips Market

The Biochips Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of life-threatening disorder and rise in geriatric population
    • Growing demand of personalized medicine for the treatment of cancer
    • Increasing Demand for Point-of-care Testing
  • Market Restraints
    • High cost associated with the manufacturing of biochips products
  • Market Opportunities
    • Ongoing advancements in field of genomics and proteomics
    • Rising investments in the field of biotechnology from private & public sectors
  • Market Challenges
    • Stringent regulations associated with the manufacturing and implementation of biochips

Porter's Five Forces: A Strategic Tool for Navigating the Biochips Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biochips Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biochips Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biochips Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biochips Market

A detailed market share analysis in the Biochips Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biochips Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biochips Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biochips Market

A strategic analysis of the Biochips Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biochips Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACROBiosystems Inc., Agilent Technologies, Inc., Archer Materials Limited, Bio-Rad Laboratories, Inc., BioMerieux SA, Cellix Ltd. by Randox Laboratories Ltd., Diagnostic Biochips, Inc, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Horiba, Ltd., Illumina, Inc., Innovative Biochips, LLC, LI-COR, Inc., Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Micronit B.V., Nutcracker Therapeutics, Opteev, PerkinElmer Inc., Phalanx Biotech Group Inc. by WIN Semiconductors Corp., QIAGEN N.V., Sphere Fluidics Limited, Standard BioTools Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Biochips Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Arrays, DNA Chips, Lab-On-A-Chip, and Protein Chips. The Arrays is further studied across Cell Arrays and Tissue Arrays.
  • Based on Fabrication Technology, market is studied across Microarrays and Microfluidics.
  • Based on Application, market is studied across Clinical Diagnostics, Drug Discovery, and Genomics & Proteomics Source.
  • Based on End-User, market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Diagnostics Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of life-threatening disorder and rise in geriatric population
      • 5.1.1.2. Growing demand of personalized medicine for the treatment of cancer
      • 5.1.1.3. Increasing Demand for Point-of-care Testing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the manufacturing of biochips products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in field of genomics and proteomics
      • 5.1.3.2. Rising investments in the field of biotechnology from private & public sectors
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with the manufacturing and implementation of biochips
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Consumer preference for lab-on-a-chip for point-of-care diagnostics as they provide quick and accurate results
    • 5.2.2. Fabrication Technology: Extensive use of microfluidics for point-of-care diagnostics for pathogen detection
    • 5.2.3. Application: Significant role of biochips in drug discovery utilized for compound identification and target validation
    • 5.2.4. End-User: Growing preference for biochips by biotechnology & pharmaceutical companies for drug discovery and personalized medicine
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biochips Market, by Type

  • 6.1. Introduction
  • 6.2. Arrays
    • 6.2.1. Cell Arrays
    • 6.2.2. Tissue Arrays
  • 6.3. DNA Chips
  • 6.4. Lab-On-A-Chip
  • 6.5. Protein Chips

7. Biochips Market, by Fabrication Technology

  • 7.1. Introduction
  • 7.2. Microarrays
  • 7.3. Microfluidics

8. Biochips Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Diagnostics
  • 8.3. Drug Discovery
  • 8.4. Genomics & Proteomics Source

9. Biochips Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biotechnology & Pharmaceutical Companies
  • 9.4. Hospitals & Diagnostics Centers

10. Americas Biochips Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biochips Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biochips Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Archer's First-Generation Biochip gFET Design Validated by Joint Fabrication with a Foundry Partner
    • 13.3.2. Opteev Files Patent for New Multiplex Biochip
    • 13.3.3. Nutcracker Therapeutics Raises $167 Million in Series C Financing to Advance its mRNA Therapeutics and First-of-its-Kind Biochip-based Manufacturing Platform
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACROBiosystems Inc.
  • 3. Agilent Technologies, Inc.
  • 4. Archer Materials Limited
  • 5. Bio-Rad Laboratories, Inc.
  • 6. BioMerieux SA
  • 7. Cellix Ltd. by Randox Laboratories Ltd.
  • 8. Diagnostic Biochips, Inc
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. GE HealthCare Technologies, Inc.
  • 11. Horiba, Ltd.
  • 12. Illumina, Inc.
  • 13. Innovative Biochips, LLC
  • 14. LI-COR, Inc.
  • 15. Luminex Corporation by DiaSorin S.p.A.
  • 16. Merck KGaA
  • 17. Micronit B.V.
  • 18. Nutcracker Therapeutics
  • 19. Opteev
  • 20. PerkinElmer Inc.
  • 21. Phalanx Biotech Group Inc. by WIN Semiconductors Corp.
  • 22. QIAGEN N.V.
  • 23. Sphere Fluidics Limited
  • 24. Standard BioTools Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. BIOCHIPS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOCHIPS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOCHIPS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOCHIPS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOCHIPS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOCHIPS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOCHIPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOCHIPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOCHIPS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOCHIPS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOCHIPS MARKET SIZE, BY CELL ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOCHIPS MARKET SIZE, BY DNA CHIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOCHIPS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOCHIPS MARKET SIZE, BY GENOMICS & PROTEOMICS SOURCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOCHIPS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. BIOCHIPS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. BIOCHIPS MARKET, FPNV POSITIONING MATRIX, 2023